Literature DB >> 2407337

Volume growth rate of acoustic neuromas on MRI post-stereotactic radiosurgery.

S Y To1, R B Lufkin, R Rand, J D Robinson, W Hanafee.   

Abstract

Of the approximately 160 acoustic neuroma patients treated with stereotactic radiosurgery in the world up to 1987, 8 patients at UCLA Medical Center have had two or more magnetic resonance scans at least one year apart available for study (all 8 patients were treated with stereotactic radiosurgery for acoustic neuromas by the Department of Neurosurgery at the Karolinska Hospital, Stockholm, Sweden). The followup time after radiosurgery ranged from 4 to 8 years. The volume doubling rate post-stereotactic radiosurgery was calculated to be slow (763 to 888 days) in two patients, virtually arrested in five patients (doubling times larger than 2500 days) and negative (-563 days) in one patient indicating a shrinking tumor. Due to the limited sample size no radiological finding or clinical data correlated with the volume doubling times. A control patient that had no treatment for her tumor had a doubling time of 217 days for comparison.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407337     DOI: 10.1016/0895-6111(90)90140-7

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  2 in total

1.  Serial follow-up MR imaging after gamma knife radiosurgery for vestibular schwannoma.

Authors:  H Nakamura; H Jokura; K Takahashi; N Boku; A Akabane; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

Review 2.  Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields.

Authors:  Diego Martin-Sanchez; Miguel Fontecha-Barriuso; Maria Dolores Sanchez-Niño; Adrian M Ramos; Ramiro Cabello; Carmen Gonzalez-Enguita; Andreas Linkermann; Ana Belén Sanz; Alberto Ortiz
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.